161 related articles for article (PubMed ID: 19542194)
1. Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.
Haarhaus M; Fernström A; Magnusson M; Magnusson P
Nephrol Dial Transplant; 2009 Nov; 24(11):3382-9. PubMed ID: 19542194
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.
Magnusson P; Sharp CA; Magnusson M; Risteli J; Davie MW; Larsson L
Kidney Int; 2001 Jul; 60(1):257-65. PubMed ID: 11422759
[TBL] [Abstract][Full Text] [Related]
3. Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone.
Magnusson P; Larsson L; Magnusson M; Davie MW; Sharp CA
J Bone Miner Res; 1999 Nov; 14(11):1926-33. PubMed ID: 10571693
[TBL] [Abstract][Full Text] [Related]
4. The novel bone alkaline phosphatase B1x isoform in children with kidney disease.
Swolin-Eide D; Hansson S; Larsson L; Magnusson P
Pediatr Nephrol; 2006 Nov; 21(11):1723-9. PubMed ID: 16932897
[TBL] [Abstract][Full Text] [Related]
5. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
6. Calcifying human aortic smooth muscle cells express different bone alkaline phosphatase isoforms, including the novel B1x isoform.
Haarhaus M; Arnqvist HJ; Magnusson P
J Vasc Res; 2013; 50(2):167-74. PubMed ID: 23328739
[TBL] [Abstract][Full Text] [Related]
7. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
8. The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.
Haarhaus M; Fernström A; Qureshi AR; Magnusson P
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959954
[TBL] [Abstract][Full Text] [Related]
9. Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization.
Magnusson P; Farley JR
Calcif Tissue Int; 2002 Dec; 71(6):508-18. PubMed ID: 12232676
[TBL] [Abstract][Full Text] [Related]
10. Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients.
Milinković NL; Majkic-Singh NT; Ignjatović SD; Lezaić VD; Pejanović SD; Jovanovic DB
Clin Lab; 2012; 58(7-8):747-53. PubMed ID: 22997975
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human bone alkaline phosphatase isoforms: comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography.
Sharp CA; Linder C; Magnusson P
Clin Chim Acta; 2007 Apr; 379(1-2):105-12. PubMed ID: 17289010
[TBL] [Abstract][Full Text] [Related]
12. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
[TBL] [Abstract][Full Text] [Related]
13. Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts.
Magnusson P; Sharp CA; Farley JR
Clin Chim Acta; 2002 Nov; 325(1-2):59-70. PubMed ID: 12367767
[TBL] [Abstract][Full Text] [Related]
14. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).
Manghat P; Souleimanova I; Cheung J; Wierzbicki AS; Harrington DJ; Shearer MJ; Chowienczyk P; Fogelman I; Nerlander M; Goldsmith D; Hampson G
Bone; 2011 May; 48(5):1127-32. PubMed ID: 21281749
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
Salam S; Gallagher O; Gossiel F; Paggiosi M; Khwaja A; Eastell R
J Am Soc Nephrol; 2018 May; 29(5):1557-1565. PubMed ID: 29555831
[No Abstract] [Full Text] [Related]
16. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
Hitz MF; Jensen JE; Eskildsen PC
Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
[TBL] [Abstract][Full Text] [Related]
17. Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation.
Avbersek-Luznik I; Gmeiner Stopar T; Marc J
Clin Chem Lab Med; 2007; 45(8):1014-8. PubMed ID: 17579570
[TBL] [Abstract][Full Text] [Related]
18. Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: cross-sectional study.
Kusec V; Smalcelj R; Cvijetić S; Rozman B; Skreb F
Croat Med J; 2000 Dec; 41(4):396-400. PubMed ID: 11063762
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
Mitra D; Elvins DM; Collins AJ
J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
